United StatesUnited States (Mon - Fri) 09:00-21:00 - GMT -4:00 +1-567-237-4132

By

Dennis Burns
NASHVILLE, TN / ACCESSWIRE / August 12, 2021 / EV Biologics Corp, OTC Pink:YECO, today briefed shareholders on its current value compared to other public biotechnology companies in its peer group. Please view the chart at: https://www.evbiologics.com/marketcap/. CEO Daniel Mckinney commented: ‘Our market cap is less than half that of our closest listed peer. Our goal is...
Read More
NASHVILLE, TN / ACCESSWIRE / August 9, 2021 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders with further details about its NFT Warrant Dividend. Attached is a preliminary image from the 3D animation still under development that will be issued as an NFT dividend Daniel Mckinney CEO said: “this NFT will capture the stunning visual...
Read More
KUALA LUMPUR, MALAYSIA / ACCESSWIRE / August 6, 2021 / Greenpro Capital Corp. (NASDAQ:GRNQ). announce that on August 2, 2021, it has signed a Public and Private Partnerships Investment Agreement with IHTHS Corporation, with the witness of BIMP-EAGA Business Council. The goal of this new partnership is to build a Shariah Compliant Digital Finance & Economic Zone,...
Read More
KUALA LUMPUR, MALAYSIA / ACCESSWIRE / July 30, 2021 / Greenpro Capital Corp. (NASDAQ:GRNQ). GreenPro Group, a multinational one stop financing hub with a variety of services and products such as corporate advisory, wealth protection and management, venture capital and financial technology has released its digital transformation roadmap. The newly released digital transformation roadmap recognizes the...
Read More
NASHVILLE, TN / ACCESSWIRE / July 26, 2021 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders about its NFT dividend Warrant. The Company will distribute one (1) Warrant for every 100 shares of YECO common stock held. Each Warrant will be exercisable for one (1) NFT worth $300. Shareholders will have 90-days (October 28, 2021)...
Read More
NASHVILLE, TN / ACCESSWIRE / July 22, 2021 / EV Biologics Corp., (OTC PINK:YECO) today announced that it has signed a Letter of Intent (LOI) with Lonza Cell & Gene Therapy for Process Development and Gap Analysis for biomanufacturing of a novel therapeutic composition, comprising extracellular vesicles (EVs) and particles, as well as other secreted factors...
Read More
NASHVILLE, TN / ACCESSWIRE / July 19, 2021 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders about its NFT dividend. On July 14, 2021 the Company announced a dividend of 1 NFT for every 100 shares of YECO common stock. The NFTs will be distributed via a special dividend to YECO’s shareholders of record on...
Read More
CHEYENNE, WY / ACCESSWIRE / July 14, 2021 / EV Biologics Corp, OTC PINK:YECO, today announced that it will distribute a dividend of one (1) Non-Fungible Token (NFT) for every 100 shares of YECO common stock held on the record date. Shareholders possessing less than 100 shares will not be eligible for this special dividend. The...
Read More
CHEYENNE, WY / ACCESSWIRE / June 14, 2021 / EV Biologics Corp (OTC PINK:YECO) today announced that it has completed all its filings on OTC Markets and is now Pink Current. Being current and Penny Stock Exempt allows the majority of brokers to trade in our stock. CEO Daniel Mckinney, said ‘we are pleased to be...
Read More
CHEYENNE, WY / ACCESSWIRE / May 19, 2021 / EV Biologics Corp., OTC PINK:YECO, is taking this opportunity to update our shareholders and other investors concerning the status of our name change submission to the Financial Industry Regulatory Authority (FINRA). As some might be aware, such submissions can be a lengthy and complex process, requiring notarized...
Read More
1 2 3 4 5

About the author

Hi, my name is Dennis Burns, the Investor Relations (IR) and Business Development Contact at Greenpro Capital Corp. (GRNQ). I hope you enjoyed our website and the press releases. For any inquiries, please feel free to contact me at (567)-237-4132 or at dburns@nvestrain.com